Form 4 holding
SVP, Finance
Allogene Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 88,881
- Estimated value
- $282,144
- Report date
- 10 Aug 2023
- Price
- $3.17
- Ownership
- Direct
Yinlin Jack Chen - SVP, Finance at Allogene Therapeutics, Inc.
Issuer-level insider activity
- Role
- SVP, Finance
- Issuer ticker
- ALLO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Yinlin Jack Chen since 10 Sep 2025
Reported holdings for Yinlin Jack Chen in Allogene Therapeutics, Inc.
Form 4 holding
SVP, Finance
Allogene Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 39,160
- Estimated value
- Report date
- 10 Aug 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Yinlin Jack Chen in Allogene Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.